These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1105 related articles for article (PubMed ID: 23993863)

  • 21. Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization.
    Rath BH; Wahba A; Camphausen K; Tofilon PJ
    Cancer Med; 2015 Nov; 4(11):1705-16. PubMed ID: 26518290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells.
    Tchoghandjian A; Jennewein C; Eckhardt I; Rajalingam K; Fulda S
    Cell Death Dis; 2013 Mar; 4(3):e564. PubMed ID: 23538445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells.
    Spina R; Voss DM; Asnaghi L; Sloan A; Bar EE
    Oncotarget; 2016 Jan; 7(1):459-72. PubMed ID: 26575950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular Vesicles Induce Mesenchymal Transition and Therapeutic Resistance in Glioblastomas through NF-κB/STAT3 Signaling.
    Schweiger MW; Li M; Giovanazzi A; Fleming RL; Tabet EI; Nakano I; Würdinger T; Chiocca EA; Tian T; Tannous BA
    Adv Biosyst; 2020 Dec; 4(12):e1900312. PubMed ID: 32519463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
    Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
    J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The landscape of the mesenchymal signature in brain tumours.
    Behnan J; Finocchiaro G; Hanna G
    Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
    Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
    Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem cell signature in glioblastoma: therapeutic development for a moving target.
    Nakano I
    J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
    Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
    PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KLF6 depletion promotes NF-κB signaling in glioblastoma.
    Masilamani AP; Ferrarese R; Kling E; Thudi NK; Kim H; Scholtens DM; Dai F; Hadler M; Unterkircher T; Platania L; Weyerbrock A; Prinz M; Gillespie GY; Harsh GR; Bredel M; Carro MS
    Oncogene; 2017 Jun; 36(25):3562-3575. PubMed ID: 28166199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting NF-κB in glioblastoma: A therapeutic approach.
    Friedmann-Morvinski D; Narasimamurthy R; Xia Y; Myskiw C; Soda Y; Verma IM
    Sci Adv; 2016 Jan; 2(1):e1501292. PubMed ID: 26824076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition.
    Dixit D; Sharma V; Ghosh S; Mehta VS; Sen E
    Cell Death Dis; 2012 Feb; 3(2):e271. PubMed ID: 22318540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-derived fibulin-3 activates pro-invasive NF-κB signaling in glioblastoma cells and their microenvironment.
    Nandhu MS; Kwiatkowska A; Bhaskaran V; Hayes J; Hu B; Viapiano MS
    Oncogene; 2017 Aug; 36(34):4875-4886. PubMed ID: 28414309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma.
    Moreno M; Pedrosa L; Paré L; Pineda E; Bejarano L; Martínez J; Balasubramaniyan V; Ezhilarasan R; Kallarackal N; Kim SH; Wang J; Audia A; Conroy S; Marin M; Ribalta T; Pujol T; Herreros A; Tortosa A; Mira H; Alonso MM; Gómez-Manzano C; Graus F; Sulman EP; Piao X; Nakano I; Prat A; Bhat KP; de la Iglesia N
    Cell Rep; 2017 Nov; 21(8):2183-2197. PubMed ID: 29166609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells.
    Chandran UR; Luthra S; Santana-Santos L; Mao P; Kim SH; Minata M; Li J; Benos PV; DeWang M; Hu B; Cheng SY; Nakano I; Sobol RW
    Genom Data; 2015 Sep; 5():333-336. PubMed ID: 26251826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
    Arif T; Krelin Y; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of glioblastoma multiforme stem-like cells by inhibitor of DNA binding proteins and oligodendroglial lineage-associated transcription factors.
    Wu Y; Richard JP; Wang SD; Rath P; Laterra J; Xia S
    Cancer Sci; 2012 Jun; 103(6):1028-37. PubMed ID: 22380883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA damage-induced NF-κB activation in human glioblastoma cells promotes miR-181b expression and cell proliferation.
    Xu RX; Liu RY; Wu CM; Zhao YS; Li Y; Yao YQ; Xu YH
    Cell Physiol Biochem; 2015; 35(3):913-25. PubMed ID: 25633526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance.
    Loftus JC; Dhruv H; Tuncali S; Kloss J; Yang Z; Schumacher CA; Cao B; Williams BO; Eschbacher JM; Ross JT; Tran NL
    Mol Cancer Res; 2013 Aug; 11(8):865-74. PubMed ID: 23699535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing NUDT21 Attenuates the Mesenchymal Identity of Glioblastoma Cells via the NF-κB Pathway.
    Lou JC; Lan YL; Gao JX; Ma BB; Yang T; Yuan ZB; Zhang HQ; Zhu TZ; Pan N; Leng S; Song GJ; Zhang B
    Front Mol Neurosci; 2017; 10():420. PubMed ID: 29311812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.